#news #biotech AM-Pharma still on track with sepsis drug despite mixed phase 2 readout

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AM-Pharma still on track with sepsis drug despite mixed phase 2 readout .The Dutch biotech’s recAP candidate has shown a 40% reduction in mortality in patients with sepsis-related acute kidney injury.

from FierceBiotech: Biotech http://ift.tt/2FrntYk